Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,491,115
in 20 filings, $14.5M under 10b5-1 plans

Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ROBINS CHAD M −$14.9M CEO and Chairman sold 22% of stake
  2. RUBINSTEIN JULIE −$10.2M President and COO sold 50% of stake
  3. LO FRANCIS −$4.0M Chief People Officer sold 39% of stake
  4. NEUPERT PETER M −$3.1M Director sold 49% of stake
  5. HERSHBERG ROBERT −$748K Director sold 40% of stake
Date Insider Transaction Shares Price Value Owned after
2021-01-04 BENZENO SHARON Chief Business Development Off Option exercise · Stock Option (Right to Buy) −2,604 26,042
2021-01-04 BENZENO SHARON Chief Business Development Off Option exercise · Stock Option (Right to Buy) −2,604 54,688
2021-01-04 BENZENO SHARON Chief Business Development Off Option exercise · Common Stock (Right to Buy) −1,563 37,500
2020-12-31 Taylor Stacy L SVP and General Counsel Option exercise +4,759 $7.80 $37K 6,059
2020-12-31 Taylor Stacy L SVP and General Counsel Option exercise +1,771 $6.55 $12K 7,830
2020-12-31 Taylor Stacy L SVP and General Counsel Sale −4,529 $57.54 $261K 3,301
2020-12-31 Taylor Stacy L SVP and General Counsel Sale −1,610 $58.40 $94K 1,691
2020-12-31 Taylor Stacy L SVP and General Counsel Sale −391 $59.27 $23K 1,300
2020-12-31 Taylor Stacy L SVP and General Counsel Option exercise · Stock Option (Right to Buy) −4,759 29,167
2020-12-31 Taylor Stacy L SVP and General Counsel Option exercise · Stock Option (Right to Buy) −1,771 26,563
2020-12-31 RUBINSTEIN JULIE President Option exercise +15,000 $6.32 $95K 15,000
2020-12-31 RUBINSTEIN JULIE President Sale −7,976 $57.56 $459K 7,024
2020-12-31 RUBINSTEIN JULIE President Sale −6,386 $58.25 $372K 638
2020-12-31 RUBINSTEIN JULIE President Sale −638 $59.27 $38K 0
2020-12-31 RUBINSTEIN JULIE President Option exercise · Stock Option (Right to Buy) −15,000 380,000
2020-12-30 RUBINSTEIN JULIE President Option exercise +15,000 $6.32 $95K 15,000
2020-12-30 RUBINSTEIN JULIE President Sale −13,300 $59.55 $792K 1,700
2020-12-30 RUBINSTEIN JULIE President Sale −1,700 $60.12 $102K 0
2020-12-30 RUBINSTEIN JULIE President Option exercise · Stock Option (Right to Buy) −15,000 395,000
2020-12-30 ROBINS CHAD M CEO and Chairman Option exercise +16,520 $0.33 $5K 1,794,700

Page 76 of 120 · 2,386 trades